| abstract |
The present invention relates to a heterocyclic imidazole derivative, a preparation method thereof, and a pharmaceutical use thereof, and more particularly, a new heterocyclic imidazole derivative represented by the general formula (I), a preparation method thereof, and a pharmaceutical composition containing the same And its use as a therapeutic agent, particularly as a poly (ADP-ribose) polymerase (PARP) inhibitor. |